Cargando…

Multiple myeloma and physical activity: a scoping review

OBJECTIVES: Multiple myeloma is the second most common haematological cancer. A growing body of literature is emerging that investigates the role physical activity plays in all stages of multiple myeloma (prevention and survivorship) and to date no attempt has been made to collate and understand thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, Lee, McCourt, Orla, Henrich, Malgorzata, Paton, Bruce, Yong, Kwee, Wardle, Jane, Fisher, Abigail
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663409/ https://www.ncbi.nlm.nih.gov/pubmed/26614625 http://dx.doi.org/10.1136/bmjopen-2015-009576

Ejemplares similares

Multiple myeloma and physical activity
por: Lecat, Catherine S. Y., et al.
Publicado: (2021)

The adapted Zelen was a feasible design to trial exercise in myeloma survivors
por: Land, Joanne, et al.
Publicado: (2020)

PERCEPT myeloma: a protocol for a pilot randomised controlled trial of exercise prehabilitation before and during autologous stem cell transplantation in patients with multiple myeloma
por: McCourt, Orla, et al.
Publicado: (2020)

Physical Activity During and After Haematological Cancer Treatment: A Cross-Sectional Survey of Haematology Healthcare Professionals in the United Kingdom
por: McCourt, Orla, et al.
Publicado: (2021)

Myeloma patients’ experiences of a supervised physical activity programme: a qualitative study
por: Land, Joanne, et al.
Publicado: (2022)

Lifestyle in Multiple Myeloma - a longitudinal cohort study protocol
por: Heinrich, M., et al.
Publicado: (2016)

Fatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (MASCOT): an exploratory randomised Phase 2 trial utilising a modified Zelen design
por: Koutoukidis, Dimitrios A., et al.
Publicado: (2020)

High patient satisfaction and increased physical activity following a remote multidisciplinary team multiple myeloma clinic
por: Lecat, Catherine S. Y., et al.
Publicado: (2023)

Adaptation of the PERCEPT myeloma prehabilitation trial to virtual delivery: changes in response to the COVID-19 pandemic
por: McCourt, Orla, et al.
Publicado: (2022)

“What I wanted to do was build myself back up and prepare”: qualitative findings from the PERCEPT trial of prehabilitation during autologous stem cell transplantation in myeloma
por: McCourt, Orla, et al.
Publicado: (2023)

The impact of COVID-19 on autologous stem cell transplantation in multiple myeloma: A single-centre, qualitative evaluation study
por: Camilleri, Marquita, et al.
Publicado: (2022)

Defining Unmet Need Following Lenalidomide Refractoriness: Real-World Evidence of Outcomes in Patients With Multiple Myeloma
por: Lecat, Catherine S. Y., et al.
Publicado: (2021)

The Utility of Euroflow MRD Assessment in Real-World Multiple Myeloma Practice
por: Turner, Rose, et al.
Publicado: (2022)

Therapeutic Advancements in Multiple Myeloma
por: Gozzetti, Alessandro, et al.
Publicado: (2014)

Recall of physical activity advice was associated with higher levels of physical activity in colorectal cancer patients
por: Fisher, A, et al.
Publicado: (2015)

Editorial: Molecular Mechanisms of Multiple Myeloma
por: Gozzetti, Alessandro, et al.
Publicado: (2022)

Dual Targeting of Multiple Myeloma Stem Cells and Myeloid-Derived Suppressor Cells for Treatment of Chemotherapy-Resistant Multiple Myeloma
por: Uckun, Fatih M.
Publicado: (2021)

Multiple Myeloma Relapse as Intracranial Plasmacytoma: A Rare Presentation
por: Prakash, Amulya, et al.
Publicado: (2020)

Current Role of Radiation Therapy for Multiple Myeloma
por: Talamo, Giampaolo, et al.
Publicado: (2015)

An Uncommon Cause of Acute Encephalopathy in Multiple Myeloma
por: Al Zeyoudi, Jawaher, et al.
Publicado: (2021)

PET/CT in Multiple Myeloma: Beyond FDG
por: Matteucci, Federica, et al.
Publicado: (2021)

Editorial: T-cell directed therapies in multiple myeloma
por: Richter, Joshua, et al.
Publicado: (2023)

PIWIL1 Drives Chemoresistance in Multiple Myeloma by Modulating Mitophagy and the Myeloma Stem Cell Population
por: Wang, Yajun, et al.
Publicado: (2022)

Prognostic Value of Galectin-9 Relates to Programmed Death-Ligand 1 in Patients With Multiple Myeloma
por: Lee, Byung-Hyun, et al.
Publicado: (2021)

ACE Insertion/Deletion Polymorphism (rs4646994) Is Associated With the Increased Risk of Multiple Myeloma
por: Zmorzynski, Szymon, et al.
Publicado: (2019)

Multiple myeloma with testicular involvement: A case report
por: Yamashita, Kaori, et al.
Publicado: (2019)

Deregulation and Targeting of TP53 Pathway in Multiple Myeloma
por: Jovanović, Katarina K., et al.
Publicado: (2019)

The Role of Immunotherapy in Non-transplant Eligible Multiple Myeloma
por: Bobin, Arthur, et al.
Publicado: (2020)

Testicular plasmocytoma as an unsual late relapse of multiple myeloma
por: Karray, Omar, et al.
Publicado: (2020)

Tumor Microenvironment Proteomics: Lessons From Multiple Myeloma
por: Fernando, Rodrigo Carlini, et al.
Publicado: (2021)

Immunoglobulin D Multiple Myeloma: A Rare Variant
por: MacDougall, Kira N, et al.
Publicado: (2022)

Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma
por: Romano, Alessandra, et al.
Publicado: (2021)

Infiltration of the spinal cord and peripheral nerves in multiple myeloma
por: Su, Xiaoyun, et al.
Publicado: (2022)

Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-1801 study)
por: Song, Ga-Young, et al.
Publicado: (2022)

Inhibiting PI3K–AKT–mTOR Signaling in Multiple Myeloma-Associated Mesenchymal Stem Cells Impedes the Proliferation of Multiple Myeloma Cells
por: Heinemann, Luca, et al.
Publicado: (2022)

Role of Sphingolipids in Multiple Myeloma Progression, Drug Resistance, and Their Potential as Therapeutic Targets
por: Petrusca, Daniela N., et al.
Publicado: (2022)

An Extremely Rare Manifestation of Multiple Myeloma: An Immunoglobulin D Secreting Testicular Plasmacytoma
por: Sharma, Ashish, et al.
Publicado: (2017)

Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial
por: Royle, Kara-Louise, et al.
Publicado: (2022)

Local Radiation Therapy for Palliation in Patients With Multiple Myeloma of the Spine
por: Mark, Daniel, et al.
Publicado: (2019)

Calvarial Plasmacytoma Mimicking Meningioma as the Initial Presentation of Multiple Myeloma
por: Morgenstern, Peter, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_n097l8tdvamecu5motf2ousmas